Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : Z

Records returned : 23 (on 16 Jul 2025 at 21:50:13).

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Green
Formulations :
  • Inhalation
Restrictions / Comments:

Important

recommended for  treatment of influenza in adults and children meeting the criteria set out in NICE TA 168 and for prophylaxis of influenza in adults and children meeting the criteria set out in NICE TA 158

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important

Restricted antimicrobial - to be used on advice of microbiologist

 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Capsules
  • Oral solution
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
NHSE
R
SPC
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Restricted use - prevention of vertical transmission in babies born to HIV-positive mothers. Use as recommended in BHIVA guidelines
 
Links :
NHSE
R
SPC
Status :
Green (see narrative)
Formulations :
  • Effervescent tablets
Restrictions / Comments:

Important

Zinc inhibits copper absorption so should be taken at different times (including copper containing multivitamin and mineral supplements)

NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

4mg infusion.
Hypercalcaemia of malignancy. Bone metastases. Prevention of skeletal events.

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

5mg annual infusion

 
Links :
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

5mg infusion.

 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important
Prescribe generically. Off-label use.
 
Links :
Off Label
SPC
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Off-label. Use if inadequate response to standard acute migraine treatments.
 
Links :
Off Label
SPC
Indication :
Status :
Green
Formulations :
  • Nasal spray
  • Tablets
Restrictions / Comments:

Important
Preferred
Prescribe generically
 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important
Prescribe generically
Use orodispersible tablets in patients with swallowing difficulties, nausea or vomitting.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
See narrative
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important

Orodispersible tablets have not been agreed for addition to formulary. Please contact pharmacy for advice.

 
Links :
NFD2
SPC
Indication :
Status :
Blue
Formulations :
  • Capsules
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Oral suspension
Restrictions / Comments:

Important
Zonisamide 20mg/ml is the only licensed oral suspension available.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Status :
Non Formulary
Restrictions / Comments:

 
Links :
NFD1
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

 
Links :
SPC
Status :
Amber
Formulations :
  • Depot injection
Restrictions / Comments:

Important

Zuclopenthixol decanoate - under the LCS agreement once being prescribed in Primary Care.

 
Links :
SPC
Status :
Red
Formulations :
  • Oral drops
Restrictions / Comments:

Important

In-patient administration only (SABP).

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Zuclopenthixol acetate is an intermediate-acting antipsychotic formulation which should only be used on in-patient units for the short-term management of acute psychotic episodes and mania. When prescribing intramuscular zuclopenthixol, check that the prescription is clear and unambiguous in order to ensure the intended treatment is dispensed and administered.

 

 
Links :
R